Attorneys General Call on Congress to Pass the Combating Illicit Xylazine Act

A bipartisan coalition of 39 state and territory attorneys general called on leaders of Congress to pass the Combating Illicit Xylazine Act (H.R.1839/S.993). Xylazine is only approved by the U.S. Food and Drug Administration (FDA) as a veterinary medicine and in humans, it is known to depress breathing and heart rate, lower blood pressure, and…

Read More →

Attorneys General Urge Congress to Appropriate Funding for Legal Services Corporation

A bipartisan coalition of 37 state and territory attorneys general urge leaders of the U.S. House and Senate Appropriations Committees to allocate robust funding for the nonprofit Legal Services Corporation (LSC) in the FY2024 budget. LSC supports equal access to justice by awarding grants to nonprofit organizations that provide civil legal services to those in…

Read More →

Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)

44 plaintiff states filed suit against Teva Pharmaceuticals and 19 of the nation’s largest generic drug manufacturers alleging a broad conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs. The lawsuit was originally Connecticut, was transferred to the MDL court in Pennsylvania.  The lawsuit…

Read More →

Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)

Plaintiff states filed a third lawsuit stemming from the ongoing antitrust investigation into a widespread conspiracy by generic drug manufacturers to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States. The complaint focuses on 80 topical generic drugs  and names 26 corporate Defendants and 10…

Read More →

New York et al. v. Meta (originally Facebook Inc.), No. 20-3589 (D.D.C.)

Forty-eight plaintiff states filed a lawsuit against Facebook Inc., alleging that the company harms the public by illegally stifling competition to protect its monopoly power. The states alleged that, over the last decade, the social networking giant illegally acquired competitors in a predatory manner and cut services to smaller firms that threatened its power, depriving…

Read More →

Attorneys General Urge FinCEN to Provide Timely Corporate Transparency Information to State, Local Entities

The National Association of Attorneys General (NAAG) called on the Financial Crimes Enforcement Network (FinCEN) to allow state, local, and tribal entities to have appropriate and timely access to corporate ownership information critical to fighting crime and terrorism. FinCEN seeks comments on recently proposed requirements for access to a national database that will be created…

Read More →

United States et al. v. Google LLC, No. 1:23-cv-00108 (E.D. Va. Jan. 24, 2023)

The United States and eight plaintiff states sued Google for monopolizing multiple digital advertising technology products in violation of Sections 1 and 2 of the Sherman Act. The complaint alleges that Google monopolizes key digital advertising technologies, collectively referred to as the “ad tech stack,” that website publishers depend on to sell ads and that…

Read More →

NAAG Supports FCC Proposal to Put in Place Anti-Robotext Protections

The National Association of Attorneys General (NAAG) supported the Federal Communications Commission’s (FCC) proposal to help cut down on unwanted text messages by requiring mobile wireless providers to block texts from invalid, unassigned, or unused numbers, and from numbers on a Do Not Originate (DNO) list. The bipartisan coalition of 51 attorneys general support the…

Read More →

NAAG Urges DEA and SAMSHA to Extend Telehealth Capabilities for Opioid Use Disorder Treatment

A bipartisan group of 45 state attorneys general urge the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) to permanently extend telehealth flexibilities after the expiration of the public health emergency for prescribing buprenorphine, one of three Food and Drug Administration (FDA) approved medications for treating opioid use disorder. Buprenorphine…

Read More →

NAAG Calls on the FCC to Require Voice Service Providers to Increase Anti-Robocall Protections

The National Association of Attorneys General (NAAG) called on the Federal Communication Commission (FCC) to require the telephone providers that route calls across the U.S. telephone network to implement more rigorous measures to prevent illegal and fraudulent robocalls from bombarding Americans. The FCC is proposing expanding many of these rules to those few phone companies…

Read More →